权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Epigenomics, RNA and Gene Regulation

表观基因组学、RNA 和基因调控

基本信息

批准号：
10619461
负责人：
MICHAEL F CAREY
金额：
$ 15.53万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
1996
资助国家：
美国
起止时间：
1996-12-01 至 2025-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10619461
关键词：
Achievement Address Animal Model Animals Bioinformatics Biological Models Biological Process Biology Breast Cancer Biology Cancer Burden Cancer Center Support Grant Catchment Area Cell Cycle Cell Differentiation process Cell model Cells Chromatin Clinical Collaborations Colorectal Computer Analysis County Coupled DNA Sequence Alteration DNA sequencing Data Dependence Development Diagnostic Direct Costs Disease Doctor of Philosophy Ensure Environment Faculty Fostering Funding Gene Expression Regulation Genes Genetic Transcription Genome Genomics Goals High-Throughput Nucleotide Sequencing Histone Deacetylase Inhibitor Human Resources Immune response Inflammation Informatics Institution Jonsson Comprehensive Cancer Center of University of California Los Angeles Journals Knowledge Knowledge acquisition Link Liver Los Angeles Lung Malignant Neoplasms Metabolic Methodology Modeling Molecular Organism Paper Pathologic Processes Peer Review Physiological Processes Plants Postdoctoral Fellow Productivity Prostate Proteomics Publications RNA Regulation Regulator Genes Research Research Personnel Schools Science Structure Students Technology Therapeutic Training Training Programs Translating Translations Viral Viral Oncogene Yeasts cancer cell cancer genome cancer initiation cancer type cell free DNA epigenome epigenomics expectation genome-wide health disparity innovation insight interest large datasets lipid metabolism member metaplastic cell transformation new technology next generation novel novel diagnostics novel strategies permissiveness pre-clinical preclinical study prognostic programs recruit stem cell self renewal tool translational applications translational physician translational scientist treatment strategy tumor tumor progression tumorigenesis

项目摘要

EPIGENOMICS, RNA, AND GENE REGULATION RESEARCH PROGRAM (ERGR) ABSTRACT The Epigenomics, RNA, and Gene Regulation Research Program (ERGR), led by Michael Carey, PhD (Program Director) and Siavash Kurdistani, MD (Program Co-Director), is the most basic of the JCCC Research Programs. Program objectives are to support exceptional JCCC researchers and teams, to ensure ongoing Program robustness with strategic recruitments and training, and to innovate breakthroughs in gene regulation, RNA biology, and bioinformatics with impact in cancer. The expectation is that ERGR investigator discoveries will uncover vulnerabilities for targeting by novel diagnostic and anti-tumor treatment strategies. ERGR investigators employ a range of model systems, from yeast and plants to cancer cells and small animals, to elucidate mechanisms of gene regulation, from chromatin and transcription to RNA biology, to understand and dissect alterations in cancer. Program studies extend to physiological and pathological processes implicated in cancer including cell differentiation, inflammation, and lipid metabolism. ERGR leads in developing new technologies and methodologies, such as advanced informatics for high-throughput experimental tools, and provides expertise to researchers in all six JCCC Research Programs. Although focused on epigenomics and gene regulatory mechanisms, ERGR strives to translate new knowledge to preclinical and clinical settings, with Program discoveries underpinning clinical HDAC inhibitor development and cell free DNA diagnostics. The ERGR Research Program has 33 members drawn from five UCLA schools and partner institution, Caltech, representing 13 departments. As of March 1, 2019, Program support was $11,256,579 in direct cost funding, of which $9,904,290 (88%) is peer-reviewed, and $1,031,199 (9%) is NCI funding. Program discoveries resulted in 506 publications during the prior project period, of which 10% were intra-programmatic collaborations, and 19% were inter-programmatic collaborations. In addition, 271 (54%) Program publications were with external collaborators and 337 (67%) of publications were in high-impact (IF ≥10, or field leading) journals. As an example, one achievement in the prior period was enormous strengthening of bioinformatics via recruitment. Scientifically, studies revealed how a viral oncogene exploits cell machinery to induce cell cycling and simultaneously block an anti-viral immune response. Additionally, new insights into the metabolic dependencies of stem cell self- renewal and differentiation informed how such dependencies may provide a permissive environment for tumorigenesis in the presence of pre-disposing genetic mutations. ERGR investigators cultivate a collegial environment with many structured opportunities to exchange ideas, research findings, and scientific discussions amongst Program faculty, postdocs, and students. These interactions help establish valuable collaborations that raise the quality of Program science and inspire interest in cancer-related problems. An ERGR Program guiding principle is to foster the discovery of fundamental biological processes whose alterations may contribute to cancer development and progression, which supports the ultimate JCCC goal of defeating this dreaded disease.

表观基因组学、rna和基因调控研究计划（ergr）